APOC3 and diabetic kidney disease: In the FinnDiane study (Sigfrids, 2022), diabetic kidney disease (DKD) progression was assessed in terms of remnant cholesterol and apolipoprotein C-III (apoC-III), both key components of the triglyceride-rich lipoprotein metabolism [47].